skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News


News Content
Daewoong Pharmaceutical acquires the sales rights for Vivotif, an orally injected typhoid fever vaccine.
Date 2019-03-19 Hit 1436
News List
Prev Daewoong Pharmaceutical leads innovation of local business by focusing on technology transfer with Trapaco, the largest pharmaceuticals company in Vietnam.
Next Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia